Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy-Reference-Cited by-同舟云学术

Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy

Published:2011-08 Issue:2 Volume:122 Page:361-365
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lee Yoo-Young,Choi Chel Hun,Do In-Gu,Song Sang Yong,Lee Wooseok,Park Hwang Shin,Song Tae Jong,Kim Min Kyu,Kim Tae-Joong,Lee Jeong-Won,Bae Duk-Soo,Kim Byoung-Gie

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference24 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Berek & Novak's gynecology, 14th edition;Berek,2007

3. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J Natl Cancer Inst,2003

4. Role of copper transporters in the uptake and efflux of platinum containing drugs;Safaei;Cancer Lett,2006

5. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells;Blair;Mol Pharmacol,2010

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential;Non-coding RNA Research;2024-12

2. Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer;Mini-Reviews in Medicinal Chemistry;2024-08

3. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics;Cell Communication and Signaling;2024-05-01

4. The effect of lipid metabolism on cuproptosis-inducing cancer therapy;Biomedicine & Pharmacotherapy;2024-03

5. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition;Biochemical Pharmacology;2024-03